Reaction

Bicytopenia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,911 reports · 76 co-occurring drugs

As of the last recalculation, Bicytopenia appears in 1,911 FAERS reports alongside 76 co-occurring drug terms. The strongest observed disproportionality signal is LINEZOLID (PRR 42.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Linezolid	109	42.2	42.4
Brentuximab Vedotin	26	28.0	28.1
Valganciclovir Hydrochloride Powder,	27	24.4	24.5
Valganciclovir	37	21.8	21.8
Valganciclovir Hydrochloride	37	21.8	21.8
Pemetrexed Disodium	69	20.4	20.5
Pemetrexed	38	19.7	19.7
Atovaquone	13	17.7	17.7
Ganciclovir	16	17.2	17.2
Ganciclovir Sodium	16	16.6	16.6
Posaconazole	23	15.6	15.6
Carboplatin	165	15.4	15.4
Iron Sucrose	13	14.9	15.0
Sodium Bicarbonate	30	14.3	14.3
Sodium Bicarbonate Injection,	30	14.3	14.3
Anti-Thymocyte Globulin (Rabbit)	10	13.6	13.6
Dextrose	16	13.3	13.4
Dextrose Monohydrate	16	13.1	13.2
Gemcitabine Hydrochloride	62	13.1	13.1
Valproate Sodium	24	12.8	12.8
Sulfamethoxazole And Trimethoprim	91	12.3	12.3
Rifampicin	11	11.9	11.9
Pyrazinamide	10	11.7	11.7
Fosaprepitant Dimeglumine	14	11.2	11.2
Meropenem	31	10.7	10.7
Gemcitabine	37	10.4	10.4
Anastrozole Tablets	19	9.7	9.7
Instalax Polyethylene Glycol 3350	11	9.7	9.7
Piperacillin Sodium,Tazobactam Sodium	23	9.5	9.6
Aprepitant	16	9.5	9.5
Polyethylene Glycol 400	11	9.5	9.5
Valacyclovir	35	9.3	9.3
Ribociclib	26	9.1	9.1
Cisplatin	63	9.0	9.1
Rabeprazole	18	8.9	8.9
Colchicine	21	8.8	8.8
Enoxaparin Sodium	45	8.7	8.7
Etoposide	57	8.7	8.7
Amoxicillin And Clavulanate Potassium	21	8.5	8.5
Guanfacine	6	8.3	8.3
Tretinoin	6	8.1	8.1
Dutasteride	6	8.1	8.1
Aripiprazole Oral	29	7.7	7.7
Aripiprazole Orally Disintegrating	29	7.7	7.7
Sodium Chloride Tablet	51	7.7	7.7
Sodium Chloride Tablets	51	7.7	7.7
Eplerenone	9	7.7	7.7
Paclitaxel (Aibumin-Bound)	56	7.6	7.6
Pembrolizumab	71	7.6	7.6
Paclitaxel	66	7.5	7.5
Sodium Chloride	52	7.3	7.3
Daptomycin	6	7.1	7.1
Ceftriaxone	21	7.0	7.0
Ceftriaxone Sodium	24	6.9	6.9
Nebivolol	10	6.9	6.9
Desoximetasone	10	5.7	5.7
Darbepoetin Alfa	28	5.7	5.7
Vincristine Sulfate	15	5.6	5.6
Ifosfamide	11	5.6	5.6
Abemaciclib	10	5.5	5.5
Clobazam	12	5.4	5.4
Durvalumab	10	5.4	5.4
Azacitidine	13	4.8	4.8
Lacosamide	16	4.7	4.7
Pertuzumab	11	4.4	4.4
Romiplostim	6	4.4	4.4
Carfilzomib	11	4.3	4.3
Dabrafenib	8	4.1	4.2
Irinotecan Hydrochloride	4	3.4	3.4
Fam-Trastuzumab Deruxtecan-Nxki	3	3.2	3.2
Atezolizumab	11	3.1	3.1
Ixazomib	8	3.0	3.0
Paliperidone Palmitate	8	2.7	2.7
Lutetium Lu 177 Vipivotide Tetraxetan	3	2.5	2.5
Minoxidil Foam 5% (Womens)	6	2.0	2.0
Minoxidil	6	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.